Abstract:Abstract BACKGROUND AND AIMS Circulating histones play a crucial role in the development and progression of sepsis and is associated with high mortality. Hemadsorption with the CytoSorb® filter has been shown to non-specifically eliminate systemic circulating histones in plasma from injured patients ex vivo and in vitro. The aim of this study was to fabricate another novel hemoperfusion adsorbent for selective removal of histones in the blood of septic patients. METHOD Chitosan-cellulose composite hydrogels (CSCE) were first prepared using a liquid-liquid inversion method. Then, negatively charged heparin was grafted onto the surfaces of the CSCE hydrogels by EDC chemistry to obtain the histone sorbents (CSCEHEP hydrogels). The chemical structure of CSCEHEP hydrogels was characterized by Fourier transform infrared spectroscopy (FTIR) and its hemocompatibility was evaluated. The adsorption capacity and adsorption selectivity of CSCEHEP hydrogels for histone were then analysed by BCA protein quantitative method. Besides, the antagonistic effect of CSCEHEP hydrogels on histone-induced cytotoxicity was verified by in vitro cell experiments using HK-2 cell lines. RESULTS The obtained CSCEHEP hydrogels showed characteristic adsorption peaks of the sulfonic group at 1217 and 940 cm-1 in their FTIR spectrum, suggesting the successful immobilization of heparin onto the surface of the sorbent. The clotting time of plasma after a 30-min incubation with CSCEHEP hydrogels was significantly prolonged by 3 times while no obvious hemolysis, platelet activation, complement activation and other blood-material adverse reactions occurred during this incubation. With a heparin grafting, the adsorption capacity of CSCEHEP hydrogels towards histones (from calf thymus) increased significantly to 314.3 μg/g, with a clearance rate of 62.8%, compared to that of pristine CSCE, which is dependent on the initial histone concentrations in testing solutions. On the contrary, the adsorption capacity of bovine serum albumin by CSCEHEP hydrogels was significantly lower than that of histones, suggesting that the adsorption process of histone by CSCEHEP in plasma was selective. Meanwhile, CSCEHEP hydrogels significantly antagonized histone-induced cytotoxicity by binding histones, and the cell viability increased significantly from 47.1% (model group) to 72.0% (CSCEHEP-treat group). CONCLUSION CSCEHEP hydrogels are of good hemocompatibility and can effectively adsorb histones in PBS solution and antagonize histone-induced cytotoxicity. It is believed that the use of such a histone sorbent for extracorporeal blood purification may provide a novel insight into the modulation of aberrant immune responses in patients with sepsis.

Efficient Selective Adsorption of Cytokine IL-6 and Other Middle-Macromolecular Toxins in the Serum of Uremia Patients with Specially Designed Porous Hollow Carbon Spheres

Zwitterionic Polymers As High-Performance Coatings for Hemoperfusion Adsorbents and Their Chemisorption of Protein-Bound Toxins Through Computational Simulations

Reticular Access to Triptycene-Based Cationic Metal–organic Frameworks for Protein-Bound Uremic Toxins Sorption

Charge-biased Nanofibrous Membranes with Uniform Charge Distribution and Hemocompatibility for Enhanced Selective Adsorption of Endotoxin from Plasma

P1101A Bifunctional Adsorber Particle For The Removal Of Hydrophobic Uremic Toxins From Whole Blood Of Renal Failure Patients

Designing adsorptive membranes for removing protein-bound uremic toxins via π-π and cation-π interaction

MO283: A Novel Hemoperfusion Adsorbent for Selective Removal of Circulating Histones in Septic Blood

A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients

Adsorption capacity of poly(ether imide) microparticles to uremic toxins

Protein/Polysaccharide Composite towards Multi‐in‐one Toxin Removal in Blood with Self‐anticoagulation and Biocompatibility

A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis

Adsorption of Uremic Toxins Using Ti 3 C 2 T x MXene for Dialysate Regeneration

Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study

Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro

Adsorptive removal of uremic toxins using Zr-based MOFs for potential hemodialysis membranes

Adsorption-based strategies for removing uremic toxins from blood

Effectively Decontaminating Protein-Bound Uremic Toxins in Human Serum Albumin Cationic Frameworks

Uremic Toxins Elimination from Simulated Intestinal Serum with Mesopo-rous Silica Nanoparticles Coupled with Molecularly Imprinted Polymers and Amino Linker

Potential of electrospun fibrous membranes involving tri- n -octylphosphine oxide for selective clearance of uremic toxin p -cresol over urea and creatinine

Application of Nanoparticles as Novel Adsorbents in Blood Purification Strategies

Progress in Hemoperfusion Adsorbents of Common Toxins in Liver and Kidney Failure